NCT07415031 2026-02-17
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Mirati Therapeutics Inc.
Phase 2 Not yet recruiting
Mirati Therapeutics Inc.
Nanjing Leads Biolabs Co.,Ltd
Qilu Pharmaceutical Co., Ltd.
Sun Yat-sen University
The First Affiliated Hospital of Zhengzhou University
ChineseAMS
Columbia University
Hospital Santa Marcelina
National Cancer Institute (NCI)